Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Crinetics Pharmaceuticals announced that Vertex Pharmaceuticals will acquire the company for approximately $10 billion. The agreement, approved by both boards, is expected to close in Q3 2026 pending regulatory and shareholder approvals. Crinetics reported strong second-quarter 2026 results including $24 million in net product revenue from its comm…